Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Soldi

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Frontiers in Immunology|August 18, 2025
NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancerJoanna Palade, Eric Alsop, Nanyun Tang, et al.
Plos One|July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Leukemia|December 22, 2018
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AMLDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Science Advances|October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancerAtish Mohanty, Arin Nam, Saumya Srivastava, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Frontiers in Immunology|August 18, 2025
NK cell-derived extracellular vesicles enhance cytotoxicity and immune cell recruitment in non-small cell lung cancerJoanna Palade, Eric Alsop, Nanyun Tang, et al.
Plos One|July 11, 2020
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancerRaffaella Soldi, Tithi Ghosh Halder, Alexis Weston, et al.
Oncoimmunology|July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platformTithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Leukemia|December 22, 2018
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AMLDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Science Advances|October 13, 2023
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancerAtish Mohanty, Arin Nam, Saumya Srivastava, et al.
Pageof 3